What does Actavia Life Sciences, Inc. do?

Actavia Life Sciences, Inc. (RASP) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is RASP's market cap?

Actavia Life Sciences, Inc. (RASP) has a market capitalization of approximately $385,906, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does RASP pay a dividend?

No — Actavia Life Sciences, Inc. (RASP) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Actavia Life Sciences, Inc. (RASP) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

RASP

Actavia Life Sciences, Inc.

OTC·Biotechnology · Healthcare

$0.00$0.00+0.00%

Market cap$385.91K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−98.33%CAGR −55.91%

Select date range

FromTo

Feb 24, 2015Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

RASP does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateJun 28

Last Report DateMay 20

Reported vs Estimate−$0.00 vs $1.58

Earnings Surprise−100.0%

FinancialsFinancials Tab

Revenue$0.00

Net Income−$407.01K

Net Margin—

Operating Cash Flow−$66.42K

Capital Expenditures$4.00

Free Cash Flow−$66.42K

Return on Equity—

Return on Invested Capital3.8%

Net Debt$302.57K

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for RASP and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how RASP's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for RASP and 80,000+ other tickers.

About Actavia Life Sciences, Inc.

Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating small molecule drug candidates, with a particular emphasis on addressing acute myeloid leukemia. Established in 2013, its corporate headquarters are situated in New York, NY.

CEO: Keeren Shah
Sector: Healthcare
Industry: Biotechnology
Exchange: OTC
Employees: 1
Website: www.rasna.com

Peers

Wesana Health Holdings Inc.

Cap

$73.2K

IPIX

Innovation Pharmaceuticals Inc.

Cap

$311.0K

Latest News

News Tab

No recent news available.

Frequently Asked Questions About RASP

What does Actavia Life Sciences, Inc. do?: Actavia Life Sciences, Inc. (RASP) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is RASP's market cap?: Actavia Life Sciences, Inc. (RASP) has a market capitalization of approximately $385,906, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does RASP pay a dividend?: No — Actavia Life Sciences, Inc. (RASP) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is RASP profitable?: Actavia Life Sciences, Inc. (RASP) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.